A Real-world Multicenter Outpatient Experience of Ceftolozane/Tazobactam

BACKGROUND: Ceftolozane/tazobactam (C/T) is indicated for the treatment of complicated intra-abdominal infection (IAI), complicated urinary tract infection (UTI), and hospital-acquired/ventilator-associated bacterial pneumonia caused by susceptible bacteria. As real-world data are limited, we report...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Anglen, Lucinda J, Schroeder, Claudia P, Couch, Kimberly A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167983/
https://www.ncbi.nlm.nih.gov/pubmed/37180591
http://dx.doi.org/10.1093/ofid/ofad173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167983/
https://www.ncbi.nlm.nih.gov/pubmed/37180591
http://dx.doi.org/10.1093/ofid/ofad173

Ejemplares similares